TerminatedNot Applicable

Diabetes and Smoking Cessation: a Gender-Oriented Study

Stopped: Recruitment rate too low (COVID-19 pandemic), end of funding

Switzerland48 participantsStarted 2018-03-01

Plain-language summary

People with diabetes still smoke at equivalent rates as non-diabetics. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes. The aim of this project is to assess the 12 months efficacy of a smoking cessation intervention tailored to diabetes and gender specificities, in a population of 500 smokers with type 2 diabetes. The secondary objectives are to assess the impact of smoking cessation on anthropometric outcomes, diabetes control and renal function and fecal microbiota.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Informed Consent as documented by signature; * Having smoked \> 100 cigarettes during his/her entire life and currently smoking cigarettes (no minimal threshold); * Having been diagnosed with a type 2 diabetes; * Being ≥ 18 years old; * Speaking and understanding French Exclusion Criteria: * Not being able to give an informed consent and follow the procedure of the study (due to dementia, psychological disorder, language problem); * Being pregnant or breastfeeding; * Being enrolled in another smoking cessation study or program or in a multi-behavioral program including smoking cessation; * Enrolment of the investigator or other research collaborators, their family members, employees and other dependent persons; * Planning to move out of Switzerland within the next year.

What they're measuring

Continuous smoking abstinence

Timeframe: Measured at 52 weeks

Trial details

NCT IDNCT03426423

SponsorCarole Clair

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-15

View on ClinicalTrials.gov More Smoking Cessation trials